Immunology

[NEWS CLIPPING] NUGEL TO COMPLETE SAFETY MONITORING FOR PHASE2

• DATE  2024-07-09
• VIEW  508

SHAPERON & HUDSON TO PARTICIPATE IN THE 2024 BIO INTERNATIONAL

• DATE  2024-07-09
• VIEW  785

SHAPERON'S NANOBODY IN INTERNATIONAL SCI JOURNAL

• DATE  2024-07-09
• VIEW  451

[NEWS CLIPPING] INTERVIEW - JANICE MARIE MCCOURT, CEO OF HUDSON

• DATE  2024-07-09
• VIEW  514

[KBR] Shaperon passes preliminary review for Kosdaq listing

• DATE  2022-05-27
• VIEW  1354

[PR Newswire] Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise

• DATE  2022-04-18
• VIEW  1239